UK Research Reveals Striking Misinformation About CBD

Cannabis is a divisive plant, and people tend to have differing opinions on it. The plant is mostly known for its two primary cannabinoids, THC delta-9 (tetrahydrocannabinol) and cannabidiol (CBD). THC is the principal psychoactive agent in cannabis, and that’s what gives users the infamous psychotropic high. CBD, on the other hand, affects the body quite differently. Unlike the out of body high THC users experience, CBD is a miracle drug of sorts. Users have reported relief from chronic pain and inflammation, insomnia, anxiety, and a host of other diseases. Despite this, people often lump the two together, and a recent study carried out in the UK found out that a lot of people have trouble differentiating the two compounds.

The project was commissioned by CBD oil manufacturer Dr. Ed, and of the 2000 adults surveyed, more than three-quarters of them were confused about CBD. Although CBD oil is legal in the UK as it does not contain THC, two-thirds of the people believe the product is illegal.  Eight in ten people think that using the non-psychoactive CBD oil has the same physical effect as smoking marijuana, and more than half of the people surveyed said they would judge a friend or family member negatively if they knew they used CBD oil.

According to the study, CBD oil is mostly used by women aged 45-60, with 67% of them claiming to have taken or considered taking CBD oil. It also revealed that those aged 25-30 were the least likely to use CBD oil, with only 21% being open to the idea of using the compound. Two-thirds of the 2000 people surveyed wrongly believed that CBD use was banned in professional sports.

Dr. Edward Jones, Neuroscientist, and founder of Dr. Ed says that although cannabidiol was isolated as a compound decades ago, knowledge of its potential therapeutic value is only now becoming mainstream. “As with emerging industries,” he adds, ” regulation is loose, which has led to a great deal of misinformation and misunderstanding surrounding CBD and an awful lot of mis-selling.” He says that although marijuana itself is an addictive drug, once extracted from the plant, CBD is actually a safe and non-addictive substance with none of the side effects associated with THC, such as the feeling of being high.

The study also highlighted the lack of scientific research and evidence regarding the efficacy and side effects of CBD. Most of the evidence of CBD’s benefits is anecdotal, and this might perhaps account for the skewed impression Brits have regarding the compound.

Analysts think CBD companies in North America, such as Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Dama Financial, wouldn’t be surprised if a similar study is done in the U.S. and many people express similar views as those of the people surveyed in Britain.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

Archives

Select A Month

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722